title: Editorial: Escalation to weekly dosing in adalimumab-treated patients with active ulcerative colitis.
authors.affiliation: Department of Gastroenterology, Alfred Hospital, Melbourne, Vic., Australia. m.ward@alfred.org.au.
authors.forename: M G
authors.initials: MG
authors.lastname: Ward
authors.forename: M P
authors.initials: MP
authors.lastname: Sparrow
mesh_terms: D000893:Anti-Inflammatory Agents / Q000008:administration & dosage*; D061067:Antibodies, Monoclonal, Humanized / Q000008:administration & dosage*; D003093:Colitis, Ulcerative / Q000188:drug therapy*; D005260:Female; D006801:Humans; D008297:Male; D014409:Tumor Necrosis Factor-alpha / Q000037:antagonists & inhibitors*
chemical_list: D000893:Anti-Inflammatory Agents; D061067:Antibodies, Monoclonal, Humanized; D014409:Tumor Necrosis Factor-alpha